AU5646300A - Methods of stimulating angiogenesis - Google Patents

Methods of stimulating angiogenesis

Info

Publication number
AU5646300A
AU5646300A AU56463/00A AU5646300A AU5646300A AU 5646300 A AU5646300 A AU 5646300A AU 56463/00 A AU56463/00 A AU 56463/00A AU 5646300 A AU5646300 A AU 5646300A AU 5646300 A AU5646300 A AU 5646300A
Authority
AU
Australia
Prior art keywords
methods
stimulating angiogenesis
angiogenesis
stimulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56463/00A
Inventor
Luis Henrique Wolff Gowdak
Robert L. Grove
Edward G. Lakatta
H. Denny Liggitt
Lioubov Poliakova
Mark Talan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU5646300A publication Critical patent/AU5646300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU56463/00A 1999-02-10 2000-02-10 Methods of stimulating angiogenesis Abandoned AU5646300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11948799P 1999-02-10 1999-02-10
US60/119487 1999-02-10
PCT/US2000/003449 WO2000047235A2 (en) 1999-02-10 2000-02-10 Methods of stimulating angiogenesis

Publications (1)

Publication Number Publication Date
AU5646300A true AU5646300A (en) 2000-08-29

Family

ID=22384666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56463/00A Abandoned AU5646300A (en) 1999-02-10 2000-02-10 Methods of stimulating angiogenesis

Country Status (2)

Country Link
AU (1) AU5646300A (en)
WO (1) WO2000047235A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112338B2 (en) 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US5837283A (en) 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells
AU782714B2 (en) * 1999-09-09 2005-08-25 Regents Of The University Of California, The Cationic liposome delivery of taxanes to angiogenic blood vessels
RU2542385C2 (en) * 2012-08-31 2015-02-20 Общество с ограниченной ответственностью "НекстГен" Method for preparing pharmaceutical composition for inducing angiogenesis in tissues, pharmaceutical composition prepared by this method, and method of treating individual's tissue and/or organ ischemia
RU2612497C2 (en) 2015-05-26 2017-03-09 Общество с ограниченной ответственностью "НекстГен" Optimized nucleotide sequence and pharmaceutical compositions based thereon with sustained vegf transgene expression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000070572A (en) * 1997-01-29 2000-11-25 해우슬러 에이치 월터, 리처드 에스. 카훈 Multiple site delivery of adenoviral vector for the induction of angiogenesis
CA2301166A1 (en) * 1997-07-24 1999-02-04 Yuan-Peng Zhang Liposomal compositions for the delivery of nucleic acid catalysts
US6271209B1 (en) * 1998-04-03 2001-08-07 Valentis, Inc. Cationic lipid formulation delivering nucleic acid to peritoneal tumors
CA2337496A1 (en) * 1998-07-27 2000-02-10 Valentis, Inc. Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same

Also Published As

Publication number Publication date
WO2000047235A3 (en) 2001-01-04
WO2000047235A2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
AU3791601A (en) Treatment of coal
AU2557500A (en) Methods of making compounds
AU3771000A (en) Method of promoting angiogenesis
AU7882900A (en) Hydrotherapy bed
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
AU3082401A (en) Therapy of psoriasis
EG22530A (en) Preparation of substituted piperidin-4-ones
AU5547000A (en) Novel treatment
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU4556800A (en) Novel treatment
AU5646300A (en) Methods of stimulating angiogenesis
AU2080201A (en) Treatment of addiction disorders
AU1037901A (en) Process for the preparation of paroxetine
AU3775500A (en) Setting of gemstones
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU1601801A (en) Methods of preparing crna
AU1405001A (en) Treatment of diseases
AU4598400A (en) Method of treatment
AU2382601A (en) Novel method of treatment
AU5379200A (en) Bone stimulating factor
AU1037301A (en) Therapy of cephalic pain
AU8038400A (en) Method of treatment of influenza
AUPQ373899A0 (en) Treatment of asthma II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase